CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs) 

Single crystal X-ray diffraction analysis of low-molecular-weight active pharmaceutical ingredient crystal structures requires a single crystal of 10 μm or more, making microcrystal analysis challenging

Gold-based molecules that target cancer cells and leave healthy cells unharmed—a step towards precision cancer drugs with fewer toxic side effects

Flexible, modular system, designed for 21CFR Part 11 compliance

The D8 DISCOVER Plus with the non-coplanar arm and MONTEL Plus optics increases measured intensities by up to one order of magnitude

Experimental validation confirms the ability of artificial intelligence to accelerate drug discovery

Researchers have been looking for ways to administer the drug orally, and researchers at Carnegie Mellon University have now shown such a feat is possible

Binding Site’s Immunologicals Group is able to provide ethically sourced serum and/or plasma biological materials from a variety of infectious disease state conditions

The study, published in Nature Biomedical Engineering, is led by the Politecnico di Milano alongside the University Hospital of Basel and the University Hospital of Zurich

Two 1.2 GHz superconducting magnets have now reached full field at Bruker’s Swiss magnet factory